219 related articles for article (PubMed ID: 33518189)
1. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.
Zaman A; Rothman MS
Endocrinol Metab Clin North Am; 2021 Mar; 50(1):97-111. PubMed ID: 33518189
[TBL] [Abstract][Full Text] [Related]
2. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
4. A case of postmenopausal androgen excess.
Lambrinoudaki I; Dafnios N; Kondi-Pafiti A; Triantafyllou N; Karopoulou E; Papageorgiou A; Augoulea A; Armeni E; Creatsa M; Vlahos N
Gynecol Endocrinol; 2015 Oct; 31(10):760-4. PubMed ID: 26287476
[TBL] [Abstract][Full Text] [Related]
5. Hyperandrogenism after menopause.
Markopoulos MC; Kassi E; Alexandraki KI; Mastorakos G; Kaltsas G
Eur J Endocrinol; 2015 Feb; 172(2):R79-91. PubMed ID: 25225480
[TBL] [Abstract][Full Text] [Related]
6. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
[TBL] [Abstract][Full Text] [Related]
7. [Hyperandrogenism after menopause: Ovarian or adrenal origin?].
Sarfati J; Moraillon-Bougerolle M; Christin-Maitre S
Gynecol Obstet Fertil Senol; 2022 Oct; 50(10):675-681. PubMed ID: 35609786
[TBL] [Abstract][Full Text] [Related]
8. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
9. Management of postmenopausal virilization.
Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
[TBL] [Abstract][Full Text] [Related]
10. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
[TBL] [Abstract][Full Text] [Related]
11. A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.
Johnson JE; Hussain M; Rathore A; Wolfe K
Post Reprod Health; 2022 Mar; 28(1):51-55. PubMed ID: 35144514
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
[TBL] [Abstract][Full Text] [Related]
13. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry.
Sharma A; Kapoor E; Singh RJ; Chang AY; Erickson D
Clin Chem; 2018 Nov; 64(11):1636-1645. PubMed ID: 30068692
[TBL] [Abstract][Full Text] [Related]
15. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
16. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
17. Effects of sex steroids on women's health: implications for practitioners.
Derman RJ
Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin.
Vollaard ES; van Beek AP; Verburg FA; Roos A; Land JA
J Clin Endocrinol Metab; 2011 May; 96(5):1197-201. PubMed ID: 21307133
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary.
Krug E; Berga SL
Obstet Gynecol; 2002 May; 99(5 Pt 2):893-7. PubMed ID: 11975949
[TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]